Clinical trial
Mycophenolate Mofetil and Rapamycin as Secondary Intervention vs. Continuation…
NCT00223678 · Vanderbilt University Medical Center, Other · Completed
Key facts
| NCT number | NCT00223678 |
|---|---|
| Title | Mycophenolate Mofetil and Rapamycin as Secondary Intervention vs. Continuation of Calcineurin Inhibitors in Patients at Risk for Chronic Renal Allograft Failure |
| Official title | Mycophenolate Mofetil and Rapamycin as Secondary Intervention vs. Continuation of Calcineurin Inhibitors in Patients at Risk for Chronic Renal Allograft Failure |
| Lead sponsor | Vanderbilt University Medical Center, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Transplant |
| Intervention type | Drug |
| Interventions | Rapamycin |
| Enrollment | 20 |
| Start date | Jun 1, 2000 |
| Primary completion | Oct 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | Sep 22, 2005 |
| Last update posted | Jun 21, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: